 |
English
|
正體中文
|
简体中文
|
全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2511366
線上人數 : 160
|
|
|
資料載入中.....
|
請使用永久網址來引用或連結此文件:
http://libir.tmu.edu.tw/handle/987654321/63217
|
| 題名: | 幹細胞治療導入動物醫院之可行性分析-以桃園某動物醫院為個案研究
The Feasibility Study of implementing Stem-cell therapy in veterinary hospital — A Case study of veterinary hospital in Taoyuan Region |
| 作者: | 林耿玄
LIN, KENG-HSUAN |
| 貢獻者: | 管理學院生物科技高階管理碩士在職專班
蕭育仁 |
| 關鍵詞: | 動物幹細胞;動物免疫細胞;動物醫院;再生醫療
animal stem cell;animal immunotherapy;animal hospital |
| 日期: | 2023-01-11 |
| 上傳時間: | 2023-12-07 09:59:41 (UTC+8) |
| 摘要: | 台灣犬貓數量在2021年首度超越0~14歲之幼年人口，寵物的地位逐漸提高的主要原因在於產業生態改變與人口結構的變化，也因此為寵物醫療市場帶來龐大商機。隨著醫療技術的進步，再生醫療、細胞治療也廣泛應用在寵物上，目前已經能見到國多公司使用幹細胞治療寵物的相關慢性疾病。台灣的再生醫療產業雖已發展超過十年，然而對於幹細胞治療應用於寵物相較於其他先進國家仍較為落後，故本研究旨在建構一寵物幹細胞創新公司，能自行分離取得幹細胞並在合格場域進行動物試驗後，從中分析導入動物醫院後之效益。本研究以桃園某動物醫院進行個案研究，以市場分析、SWOT分析、PORTER五力分析等方法，探討其幹細胞治療導入醫院之可行性。研究結果發現，個案公司具備最新的醫療器材與技術且現階段僅有少數競爭者，因此在市場上具備更強大的成功關鍵因素，此外，在PORTER五力分析中，個案公司透過與世界知名幹細胞供應商合作，建立良好口碑與品質，能夠吸引更多飼主。在營收方面，本研究以世界知名市場統計作為參考，計算個案公司導入幹細胞治療後之營收狀況，推算收益成長率至少可達5%，且逐年以1.25%比例攀升。台灣幹細胞治療發展之相關法規發展較慢，但隨著大數據、人工智慧等技術的進步，再生醫療產業之發展日新月異，相信未來法規會與時俱進，以提供良好的科學環境，讓幹細胞療法治癒更多寵物，提高寵物的壽命與生活品質.
In Taiwan, the number of dogs and cats has overtaken the young population aged 0-14 for the first time in 2021. The main reason for the increasing status of pets is the changing of the industry and the changing demographics, which therefore has created huge business opportunities for the pet medical market. With advances in medical technology, regenerative medicine and stem cell therapy are also widely used in pets, and many companies are now using stem cells to treat chronic diseases in pets. Although the regenerative medicine industry in Taiwan has been developed for more than a decade, the application of stem cell therapy to pets is still lagging behind compared to other countries. Therefore, the aim of this case study is to describe an innovative pet stem cell company that can obtain stem cells on its own and conduct animal trials in qualified sites, and then analyze the benefits of introducing them to vets. In this study, a case study of a vet in Taoyuan, Taiwan was conducted to investigate the feasibility of introducing stem cell therapy into the hospital by using market analysis, SWOT analysis, and Porter's five forces analysis. In addition, Porter's five forces analysis indicated that the company has built up a good reputation and quality through its cooperation with world-renowned stem cell suppliers, and is able to attract more customers. In terms of revenue, this study uses the statistics of markets as a reference to calculate the revenue of the case company after the introduction of stem cell therapy and estimates that the revenue growth rate could be at least 5%, with an annual increase of 1.25%. However, with the advancement of technologies such as big data and artificial intelligence, the development of the regenerative medicine industry is changing rapidly. It is believed that regulations will keep pace with the times to provide a good scientific environment for stem cell therapy to cure more pets and improve their life expectancy and quality of life. |
| 描述: | 碩士
指導教授:蕭育仁
委員:陳炳全
委員:周冠男
委員:蕭育仁 |
| 資料類型: | thesis |
| 顯示於類別: | [生物科技高階管理碩士專班] 博碩士論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 151 | 檢視/開啟 |
|
在TMUIR中所有的資料項目都受到原著作權保護.
|
